Findings

What do systematic reviews say?

4,771 questions · 10,185 findings · 893 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2,109 · 20.7%GRADE not reported 1,125 · 11%Very low 2,279 · 22.4%Low 2,514 · 24.7%Moderate 1,709 · 16.8%High 449 · 4.4%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Early vs deferred AST

Global quality of life · advanced hormone‐sensitive prostate cancer

1 finding from 1 review

Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 285 participants
Moderate

Clobazam vs placebo

50% or greater reduction in seizure frequency Number of seizures · patients with drug‐resistant epilepsy

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 47 participants
Very low

Clobazam vs placebo

Seizure freedom · patients with drug‐resistant epilepsy

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 175 participants
Very low

Clobazam vs placebo

Treatment withdrawal · patients with drug‐resistant epilepsy

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 197 participants
Very low

Clobazam vs placebo

Withdrawals due to adverse events · patients with drug‐resistant epilepsy

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 150 participants
Very low

Clobazam vs placebo

50% reduction in generalised‐onset seizure frequency Not measured · patients with drug‐resistant epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Clobazam vs placebo

50% reduction in focal‐onset seizure frequency Not measured · patients with drug‐resistant epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Clobazam add‐on therapy for drug‐resistant epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Severity of post‐thrombotic syndromeb ( · adults with PTS

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 69 participants
Very low

Intervention not reported

Adverse effects ( · adults with PTS

The review found no eligible studies for this question.

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Patient satisfaction and quality of life · adults with PTS

The review found no eligible studies for this question.

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Compliance rate · adults with PTS

The review found no eligible studies for this question.

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Severity post‐thrombotic syndromeb ( · adults with PTS

The intervention showed no clear difference in severity post‐thrombotic syndromeb ( (low certainty).

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 47 participants
Low

Intervention not reported

Adverse effects ( · adults with PTS

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Moderate

Intervention not reported

Patient satisfaction and quality of life ( · adults with PTS

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Moderate

Intervention not reported

Compliance rate · adults with PTS

The review found no eligible studies for this question.

1 finding from 1 review

Compression therapy for treating post‐thrombotic syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient‐centred outcomes for oral vs IV iron

Death (all causes) · people with CKD

Patient‐centred outcomes for oral showed no clear difference in death (all causes) compared with IV iron (low certainty).

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
RR 1.12 [0.64, 1.94]
11 studies · 1952 participants
Low

Intervention not reported

Ferritin: final or change (µg/L) · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
33 studies · 3389 participants
Low

Intervention not reported

TSAT: final or change (%) · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
27 studies · 3089 participants
Low

Intervention not reported

HCT (%) · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 152 participants
Very low

Intervention not reported

ESA dose: final or change · adults and children with CKD

1 finding from 1 review

Parenteral versus oral iron therapy for adults and children with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 522 participants
Low